Edwards Lifesciences Corp (EW)
86.45
-0.79
(-0.91%)
USD |
NYSE |
Apr 18, 16:00
86.46
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Cash from Investing (Quarterly): 14.10M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.10M |
| September 30, 2023 | 89.00M |
| June 30, 2023 | 70.20M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 94.70M |
| September 30, 2022 | -201.50M |
| June 30, 2022 | 129.60M |
| March 31, 2022 | 229.50M |
| December 31, 2021 | -965.90M |
| September 30, 2021 | -377.40M |
| June 30, 2021 | -329.50M |
| March 31, 2021 | -49.70M |
| December 31, 2020 | -259.90M |
| September 30, 2020 | -126.30M |
| June 30, 2020 | -10.20M |
| March 31, 2020 | -134.70M |
| December 31, 2019 | -445.30M |
| September 30, 2019 | -12.70M |
| June 30, 2019 | -88.30M |
| March 31, 2019 | -49.50M |
| December 31, 2018 | 5.70M |
| September 30, 2018 | -254.20M |
| June 30, 2018 | 104.90M |
| March 31, 2018 | 220.30M |
| December 31, 2017 | 49.30M |
| Date | Value |
|---|---|
| September 30, 2017 | -209.50M |
| June 30, 2017 | -638.20M |
| March 31, 2017 | 151.20M |
| December 31, 2016 | 80.20M |
| September 30, 2016 | 3.90M |
| June 30, 2016 | -343.10M |
| March 31, 2016 | 47.30M |
| December 31, 2015 | 27.30M |
| September 30, 2015 | -175.60M |
| June 30, 2015 | 12.50M |
| March 31, 2015 | -180.30M |
| December 31, 2014 | 112.00M |
| September 30, 2014 | -154.80M |
| June 30, 2014 | -470.40M |
| March 31, 2014 | -119.80M |
| December 31, 2013 | -246.90M |
| September 30, 2013 | -106.50M |
| June 30, 2013 | -73.00M |
| March 31, 2013 | 13.70M |
| December 31, 2012 | 27.40M |
| September 30, 2012 | -131.90M |
| June 30, 2012 | -42.70M |
| March 31, 2012 | 68.40M |
| December 31, 2011 | -108.30M |
| September 30, 2011 | 55.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-965.90M
Minimum
Dec 2021
229.50M
Maximum
Mar 2022
-124.94M
Average
-49.70M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -152.00M |
| Boston Scientific Corp | -1.053B |
| Abbott Laboratories | -824.00M |
| Align Technology Inc | -13.32M |
| Zimmer Biomet Holdings Inc | -220.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 136.60M |
| Cash from Financing (Quarterly) | -413.20M |
| Free Cash Flow | 629.50M |
| Free Cash Flow Per Share (Quarterly) | 0.0577 |
| Free Cash Flow to Equity (Quarterly) | 34.80M |
| Free Cash Flow to Firm (Quarterly) | 35.00M |
| Free Cash Flow Yield | 1.19% |